Efficacy of Favipiravir in treatment of mild & moderate COVID-19 infection in Nepal: a multi-center, randomized, open-labelled, phase III clinical trial
Adhikari et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2021.12.109
https://c19early.org/adhikari.html